Johnson & Johnson Total Current Liabilities 2011-2026 | JNJ

Annual Total Current Liabilities Johnson & Johnson

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
54.1 B	50.3 B	46.3 B	45.2 B	42.5 B	-	36 B	31.2 B	30.5 B	27.7 B	-	25.1 B	25.7 B	24.3 B	23.1 B

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
54.1 B	23.1 B	35.5 B

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Current Liabilities	Price	% 24h	Market Cap	Country
Altimmune ALT	15 M	$ 3.47	3.74 %	$ 306 M	USA
Amgen AMGN	25.5 B	-	-	$ 188 B	USA
Amphastar Pharmaceuticals AMPH	158 M	-	-	$ 915 M	USA
I-Mab IMAB	576 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	1.62 B	-	-	$ 40.3 B	USA
Heron Therapeutics HRTX	96.1 M	-	-	$ 130 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	1.77 M	-	-1.52 %	$ 24.7 M	USA
Applied Genetic Technologies Corporation AGTC	25.2 M	-	-	$ 26.5 M	USA
ARCA biopharma ABIO	13 M	-	1052.0 %	$ 415 M	USA
AgeX Therapeutics AGE	5.91 M	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	228 M	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	45.3 M	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	5.75 M	-	10.36 %	$ 9.8 M	USA
Acasti Pharma ACST	1.93 M	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	556 M	-	-	-	Russia
Incyte Corporation INCY	1.52 B	$ 90.75	-0.03 %	$ 17.7 B	USA
Inovio Pharmaceuticals INO	42.6 M	$ 1.57	-0.63 %	$ 34.8 M	USA
Avenue Therapeutics ATXI	816 K	-	-52.27 %	$ 4.45 M	USA
Adverum Biotechnologies ADVM	22.9 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	19 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	25 M	-	-9.65 %	$ 45.9 M	USA
Ayala Pharmaceuticals AYLA	7.54 M	-	-	$ 7.46 M	Israel
Cullinan Management CGEM	37.7 M	$ 12.91	1.33 %	$ 778 M	USA
Atreca BCEL	16.3 M	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	82.4 M	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	1.83 B	-	0.49 %	$ 251 B	Cayman-islands
Calithera Biosciences CALA	14 M	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	25.6 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	63 M	-	-	$ 3.74 B	USA
Bellerophon Therapeutics BLPH	5.4 M	-	-74.18 %	$ 955 K	USA
Checkpoint Therapeutics CKPT	20.1 M	-	-	$ 169 M	USA
Clovis Oncology CLVS	125 M	-	-7.23 %	$ 13 M	USA
KalVista Pharmaceuticals KALV	45.2 M	$ 16.73	-1.59 %	$ 831 M	Britain
Aeglea BioTherapeutics AGLE	58.7 M	-	-	$ 1.01 B	USA
Denali Therapeutics DNLI	102 M	$ 21.04	4.31 %	$ 3.46 B	USA
Karyopharm Therapeutics KPTI	92.3 M	$ 6.93	-9.17 %	$ 845 K	USA
Keros Therapeutics KROS	20.4 M	$ 11.17	1.92 %	$ 416 M	USA
Akero Therapeutics AKRO	39.8 M	-	-	$ 3.67 B	USA
Arbutus Biopharma Corporation ABUS	22.5 M	$ 4.3	1.37 %	$ 714 M	Canada
Akouos AKUS	16.8 M	-	0.23 %	$ 488 M	USA